ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,532.30
0.45%
S&P ASX All Technology
3,983.90
1.06%
Brent Oil
76.385
0.00%
US Dollar vs AUD
1.60334
0.00%
Bitcoin
101,829.59
-0.57%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Acticor Biotech (ALACT) Share Price

Acticor Biotech

Acticor Biotech (ALACT)

EU
0.25
0.00
(0.00%)
Closed 02 February 3:30AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
0.25
Bid
0.001
Offer
0.09
Volume
0.00
0.00 Day's Range 0.00
0.22 52 Week Range 5.30
Market Cap
3.939M
Previous Close
0.25
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
6,449
Shares Outstanding
15,755,227
Dividend Yield
-
PE Ratio
-0.21
Earnings Per Share (EPS)
-1.18
Revenue
2.63M
Net Profit
-18.64M

About Acticor Biotech

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.acticor-biotech.com
Headquarters
Paris, Paris, Fra
Founded
-
Acticor Biotech is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALACT. The last closing price for Acticor Biotech was 0.25 €. Over the last year, Acticor Biotech shares have traded in a share price range of 0.22 € to 5.30 €.

Acticor Biotech currently has 15,755,227 shares in issue. The market capitalisation of Acticor Biotech is 3.94 € million. Acticor Biotech has a price to earnings ratio (PE ratio) of -0.21.

Ask ADVFN Intelligence (AI)

ALACT Latest News

More News

Acticor Biotech announces its liquidation proceedings

Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...

06 January 2025
Business Wire

Acticor Biotech Announces that the Court Judgment Has Been Postponed Until January 2, 2025

Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...

20 December 2024
Business Wire

Acticor Biotech Announces the Filing of a Request for Conversion of Receivership Proceedings Into Liquidation Proceedings

Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...

11 December 2024
Business Wire

Acticor Biotech Provides an Update on the Current Receivership Proceedings

Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...

06 November 2024
Business Wire

CORRECTING and REPLACING: Acticor Biotech Publishes Its Half-year Financial Results for 2024

Regulatory News: This replaces the announcement made at 17:45 on October 31 because the following statement has been deleted: “The limited review procedures for the interim financial statements...

04 November 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.250.250.2500DE
4000.250.250.2500DE
12-0.114-31.31868131870.3640.4210.2364490.30541847DE
26-0.229-47.80793319420.4790.890.22290330.51172965DE
52-4.24-94.43207126954.495.30.22502110.89419768DE
156-5.55-95.68965517245.8110.22188161.53192805DE
2600.06837.36263736260.182110.142586801.2660528DE

ALACT - Frequently Asked Questions (FAQ)

What is the current Acticor Biotech share price?
The current share price of Acticor Biotech is 0.25 €
How many Acticor Biotech shares are in issue?
Acticor Biotech has 15,755,227 shares in issue
What is the market cap of Acticor Biotech?
The market capitalisation of Acticor Biotech is EUR 3.94M
What is the 1 year trading range for Acticor Biotech share price?
Acticor Biotech has traded in the range of 0.22 € to 5.30 € during the past year
What is the PE ratio of Acticor Biotech?
The price to earnings ratio of Acticor Biotech is -0.21
What is the cash to sales ratio of Acticor Biotech?
The cash to sales ratio of Acticor Biotech is 1.5
What is the reporting currency for Acticor Biotech?
Acticor Biotech reports financial results in EUR
What is the latest annual turnover for Acticor Biotech?
The latest annual turnover of Acticor Biotech is EUR 2.63M
What is the latest annual profit for Acticor Biotech?
The latest annual profit of Acticor Biotech is EUR -18.64M
What is the registered address of Acticor Biotech?
The registered address for Acticor Biotech is WOJO BUILDING 82 AVENUE DU MAINE, PARIS, PARIS, 75014
What is the Acticor Biotech website address?
The website address for Acticor Biotech is www.acticor-biotech.com
Which industry sector does Acticor Biotech operate in?
Acticor Biotech operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALCYBCybergun
0.0002 €
(100.00%)
63.2M
TUVDSBio UV Group DS
0.015 €
(70.45%)
490.92k
CANDCandela Invest
1.70 €
(70.00%)
42
BIODSBiosynex DS
0.07 €
(39.44%)
55.52k
ALGTRGroupe Tera SA
4.10 €
(25.77%)
17.71k
MLIMLImalliance
0.282 €
(-27.32%)
1.5k
ALCARCarmat
0.822 €
(-22.60%)
3.04M
MLOCTOctopus Biosafety
0.14 €
(-21.35%)
18.55k
ALEXPOne Experience
0.386 €
(-21.22%)
933
SNGSonagi
0.80 €
(-20.00%)
800
ATOAtos SE
0.0023 €
(4.55%)
608.11M
ALVERVergnet
0.0011 €
(0.00%)
92.88M
ALCYBCybergun
0.0002 €
(100.00%)
63.2M
BCPBanco Comercial Portugues SA
0.5054 €
(0.04%)
32.95M
KPNKoninklijke KPN NV
3.491 €
(-1.77%)
16.54M

Discussion

View Full Feed
droopyeyes droopyeyes 4 minutes ago
Lmao look at this clown bashing for shares 

imo 
UMAV
delerious1 delerious1 7 minutes ago
As far as I know we are still expecting 2 important material news releases....maybe even 3... could be game-changers.... ... ....it's all good.... the milling results and the interviews....all there...plain as day....there has never been anything like it.... we turned the corner....it’s wonderful, i
NBRI
Monksdream Monksdream 7 minutes ago
LFVN
https://investorshub.advfn.com/uimage/uploads/2025/2/1/wgwhqIMG_4974.gif
LFVN
Patswil Patswil 8 minutes ago
PALM BEACH, Fla. (AP) — President Donald Trump has fired the director of the Consumer Financial Protection Bureau, Rohit Chopra, in the latest purge of a Biden administration holdover.Associated Press Economics Writer Joshua Boak. (AP Photo/J. David Ake)
By JOSH BOAK
Updated 12:16 P
FNMA
mascale mascale 8 minutes ago
Mainly, Hiru has no apparent further Canadian presence, but likely continues a relationship with expertise qualified, ERM. "Regarding Toronto - we previously used a virtual office space there, but that contract expires in February and we won't be renewing it. This aligns with our efforts to streaml
HIRU
yadotn yadotn 8 minutes ago
MRNJ>>>February 1, 2025>>>SEC

MRNJ
OTCMarkets
PUBLISH DATE
02/01/2025
"The Company is reporting under the Alternative Reporting Standard and is otherwise exempt from registration and not required to file periodic reports with the SEC"
https://www.otc
MRNJ
Guido2 Guido2 9 minutes ago
Yet, another brilliant thread by Fiderer:

https://x.com/Ny1david/status/1885724478883172629
FNMA
jesster64 jesster64 9 minutes ago
Questions for those with legal expertise.
Can discovery info be used for other lawsuits by other companys?
Can discovery info be used for future class action lawsuit by those who lost money during this time?
NWBO
Myth Myth 9 minutes ago
yep, if they rotate them out the door permanently.....

" payback time "...lol..
umustlikedat umustlikedat 11 minutes ago

Keep it going. FHFA in the crosshairs 
Myth Myth 11 minutes ago
man that is nice....
Monksdream Monksdream 12 minutes ago
PLTR
https://investorshub.advfn.com/uimage/uploads/2025/2/1/evpcxIMG_4973.gif
PLTR
georgie18 georgie18 12 minutes ago
CADL...$7.07...🥳...Bullish Engulfing Candle Reversal signal...50/200 Crossed 100/200 ready to cross...Been loading under $7...Looking for Break/Hold of $14.85 and a run at $18 Record Highs...imo...we shall see...The price will catch up to the News...

georgie18

M
CADL PDAC
georgie18 georgie18 13 minutes ago
CADL...$7.07...🥳...Bullish Engulfing Candle Reversal signal...50/200 Crossed 100/200 ready to cross...Been loading under $7...Looking for Break/Hold of $14.85 and a run at $18 Record Highs...imo...we shall see...The price will catch up to the News...

georgie18

M
CADL PDAC
TMaga TMaga 13 minutes ago
.000001
HCMC
pos_stock_hoarder pos_stock_hoarder 13 minutes ago
Works for me!
Stinger2014 Stinger2014 14 minutes ago
lol I’ll be first to admit my mistakes. MULN looked promising. Plenty of PRs but one big problem, not enough revenue to run this business. So RS and dilute over and over. So I packed my empty bags and moved on.

I fell onto the “there has to be a bottom” trap. Hope, greed, call i
MULN
georgie18 georgie18 14 minutes ago
CADL...$7.07...🥳...Bullish Engulfing Candle Reversal signal...50/200 Crossed 100/200 ready to cross...Been loading under $7...Looking for Break/Hold of $14.85 and a run at $18 Record Highs...imo...we shall see...The price will catch up to the News...

georgie18

M
CADL
Royal Dude Royal Dude 14 minutes ago
Yes we will see (JPM,COOP, WMI) stock and direct Bonds from JPM in Series A and their own and creations this past summer by JPM.of preferred. JMO
JPM
Myth Myth 14 minutes ago
Pentagon removes major media outlets, including NBC News, from dedicated workstations as part of a new 'rotation program'

https://www.yahoo.com/news/pentagon-removes-major-media-outlets-080157457.html
Monksdream Monksdream 15 minutes ago
HOOD
https://investorshub.advfn.com/uimage/uploads/2025/2/1/uckofIMG_4972.gif
HOOD
Mr. Dragon Mr. Dragon 15 minutes ago
"Short squeeze" "lock up your shares"
Those phrases are of a language all its own.....OTC idiot speak.
DPLS
Elroy Jetson Elroy Jetson 16 minutes ago
Trump advisor Richard Grenell, who negotiated the deal with Venezuela returned to the U.S. from Caracas Friday evening with six Americans who had been [url=https://www.wsj.com/world/americas/trump-envoy-looks-for-venezuela-deportation-deal-in-rare-caracas-visit-499a03e5?mod=article_inline]detained
declaes declaes 17 minutes ago
Hahahaha 😆 😂 

Yeah right. The increase to 30,000,000 is going to cover that. 

Man I need to deblock you! You are hilarious. Hilarious stupid!
GRST

Your Recent History

EU
ALACT
Acticor Biotech
BIT
S27844
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads